Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am J Physiol Lung Cell Mol Physiol 292: L1002-L1012, 2007. First published January 5, 2007; doi:10.1152/ajplung.00161.2006.-Hypoxic pulmonary vasoconstriction (HPV) occurs with ascent to high altitude and can contribute to development of high altitude pulmonary edema (HAPE). Vascular smooth muscle contains carbonic anhydrase (CA), and acetazolamide (AZ), a CA inhibitor, blunts HPV and might be useful in the prevention of HAPE. The mechanism by which AZ impairs HPV is uncertain. Originally developed as a diuretic, AZ also has direct effects on systemic vascular smooth muscle, including modulation of pH and membrane potential; however, the effect of AZ on pulmonary arterial smooth muscle cells (PASMCs) is unknown. Since HPV requires Ca 2ϩ influx into PASMCs and can be modulated by pH, we hypothesized that AZ alters hypoxia-induced changes in PASMC intracellular pH (pHi) or Ca 2ϩ concentration ([Ca 2ϩ ]i). Using fluorescent microscopy, we tested the effect of AZ as well as two other potent CA inhibitors, benzolamide and ethoxzolamide, which exhibit low and high membrane permeability, respectively, on hypoxia-induced responses in PASMCs. Hypoxia caused a significant increase in [Ca 2ϩ ]i but no change in pHi. All three CA inhibitors slightly decreased basal pH i, but only AZ caused a concentrationdependent decrease in the [Ca 2ϩ ]i response to hypoxia. AZ had no effect on the KCl-induced increase in [Ca 2ϩ ]i or membrane potential. N-methyl-AZ, a synthesized compound lacking the unsubstituted sulfonamide group required for CA inhibition, had no effect on pHi but inhibited hypoxia-induced Ca 2ϩ responses. These results suggest that AZ attenuates HPV by selectively inhibiting hypoxia-induced Ca 2ϩ responses via a mechanism independent of CA inhibition, changes in pHi, or membrane potential. pulmonary vascular smooth muscle; intracellular Ca 2ϩ ALVEOLAR HYPOXIA, AS OCCURS with ascent to high altitude or chronic lung diseases, results in hypoxic pulmonary vasoconstriction (HPV). Exaggerated HPV causes high altitude pulmonary edema (2) and may complicate the course of patients with chronic cardiopulmonary disease. Despite extensive study, the exact cellular mechanisms by which hypoxia induces HPV remain poorly understood. HPV is generally believed to require Ca 2ϩ influx into pulmonary arterial smooth muscle cells (PASMCs), as HPV is attenuated by removal of extracellular Ca 2ϩ and by antagonists of voltage-gated Ca 2ϩ channels (25, 27, 34, 40 -42, 48). HPV can also be modulated by changes in intracellular pH (pH i ) (33) and extracellular pH (21).
pulmonary vascular smooth muscle; intracellular Ca 2ϩ ALVEOLAR HYPOXIA, AS OCCURS with ascent to high altitude or chronic lung diseases, results in hypoxic pulmonary vasoconstriction (HPV). Exaggerated HPV causes high altitude pulmonary edema (2) and may complicate the course of patients with chronic cardiopulmonary disease. Despite extensive study, the exact cellular mechanisms by which hypoxia induces HPV remain poorly understood. HPV is generally believed to require Ca 2ϩ influx into pulmonary arterial smooth muscle cells (PASMCs), as HPV is attenuated by removal of extracellular Ca 2ϩ and by antagonists of voltage-gated Ca 2ϩ channels (25, 27, 34, 40 -42, 48) . HPV can also be modulated by changes in intracellular pH (pH i ) (33) and extracellular pH (21) .
When taken prior to ascent, acetazolamide (AZ), a carbonic anhydrase (CA) inhibitor, can prevent the development of acute mountain sickness (44) through its effects on renal bicarbonate reabsorption and chemoreceptor activity to increase ventilation and arterial oxygenation. Work in intact animals and isolated perfused lung preparations has demonstrated that AZ also attenuates the magnitude of HPV and slows the onset of the response (7, 8, 15) . The mechanisms by which this occurs remain uncertain. As a respiratory stimulant, AZ raises alveolar PO 2 and by this mechanism might blunt HPV; however, a direct effect independent of ventilationinduced changes in alveolar PO 2 is also evident since AZ inhibits HPV when ventilation, alveolar PO 2 , and PCO 2 are carefully controlled or held constant (7, 8, 15) . Vascular smooth muscle contains CA (3) , and AZ causes vasodilation in systemic blood vessels (5, 28, 29) . Mechanisms involved may include modulation of K ϩ channels, membrane potential (E m ), Ca 2ϩ signaling, or pH i (28, 29) . Furthermore, in various cell types, CA inhibitors block Ca 2ϩ channels (13, 17, 26, 55) , inhibit a Cl Ϫ -dependent ATPase (5) , and activate Ca 2ϩ -activated K ϩ channels (29, 46, 47) . The effect of AZ and/or CA inhibition on PASMC function is unknown.
Based on these considerations, we hypothesized that AZ blunts HPV by CA inhibition via modulation of pH i , E m , or intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in PASMCs. To test this hypothesis, we used fluorescent microscopy and the Ca 2ϩ -, E m -, and pH-sensitive dyes, fura-2, DiBAC 4 (3), and 2Ј,7Ј-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF), respectively, to determine the effect of hypoxia and other agonists on PASMC Ca 2ϩ , E m , and pH i and the ability of AZ to modulate these responses. To determine whether the effect of AZ is attributable to CA inhibition, we tested another powerful sulfonamide CA inhibitor, ethoxzolamide (EZ) (24) , and N-methyl-AZ (N-Meth-AZ), in which one of the amine hydrogens of the sulfonamide moiety (SO 2 NH 2 ) responsible for CA inhibition is replaced with a methyl group (SO 2 NHCH 3 ) to prevent binding to CA (23, 35) . To determine whether AZ inhibits a membrane-bound CA with its activity oriented to the extracellular space or an intracellular cytosolic isozyme, we used benzolamide (BZ), a potent hydrophilic cell-impermeant sulfonamide CA inhibitor (24) . A portion of these results has been described previously (43) .
METHODS

Isolation of PASMCs.
All procedures and protocols in this study were approved by the Johns Hopkins University Animal Care and Use Committee. The method for obtaining single PASMCs has been described previously (39) . Intrapulmonary arteries (200 -600 m outer diameter) were isolated from male Wistar rats (250 -350 g) and cleaned of connective tissue. After removal of the endothelial cells, the arteries were allowed to recover for 30 min in cold (4°C) HBSS containing (in mM) 130 NaCl, 5 KCl, 1.2 MgCl 2, 1.5 CaCl2, 10 N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES), and 10 glucose, with pH adjusted to 7.2 with 5 M NaOH, followed by 20 min in reduced-Ca 2ϩ (20 M CaCl2) HBSS at room temperature. The tissue was enzymatically digested in reduced-Ca 2ϩ HBSS containing collagenase (type I; 1,750 U/ml), papain (9.5 U/ml), bovine serum albumin (2 mg/ml), and dithiothreitol (1 mM) at 37°C for 20 min. Following digestion, single smooth muscle cells were dispersed by gentle trituration with a wide-bore transfer pipette in Ca 2ϩ -free HBSS, and the cell suspension was placed on 25-mm glass cover slips. PASMCs were transiently cultured in Ham's F-12 media supplemented with 0.5% fetal bovine serum and 1% penicillin/streptomycin for 24 -48 h before study.
Measurement of [Ca 2ϩ ]i. The methods for measurement of [Ca 2ϩ ]i have been described previously (51) . PASMCs were placed in a Em measurements. Changes in Em were measured using the fluorescence dye DiBAC4(3), which was excited at 490 nm and detected at 510 nm. Cells were loaded by continuous perfusion with Krebs solution containing 500 nM DiBAC 4(3) for at least 15 min before beginning measurements to insure stable uptake of dye. Baseline DiBAC 4(3) fluorescence was monitored for 5 min with control Krebs, followed by 10 min with Krebs in the presence or absence of AZ (100 M). At the end of this period, cells were challenged with KCl (60 mM) or endothelin-1 (ET-1; 10 Ϫ8 M). Since DiBAC4(3) fluorescence is detected at a single wavelength, any change in the concentration of the dye in the perfusion medium (i.e., differing concentrations between perfusion reservoirs) could result in a change in fluorescence that is not due to a change in E m. To minimize the possibility of this type of error, all experiments were performed by perfusing from a single reservoir into which AZ, KCl, or ET-1 were dissolved directly.
CA inhibitors. AZ and EZ were obtained from Sigma Scientific. BZ was a gift from Dr. Thomas H. Maren (University of Florida, Department of Pharmacology). The synthesis and purification of N-Meth-AZ followed that described by Maren (23) . In N-Meth-AZ, one of the amine hydrogens of the sulfonamide moiety (SO 2NH2) responsible for CA inhibition by AZ is replaced with a methyl group (SO 2NHCH3) to prevent binding to CA, but the rest of the molecule remains unaltered in terms of its general size, aromatic ring structure, and charge characteristics. Figure 1 shows the chemical structures of the four sulfonamides, molecular weight, inhibition constant against CA, lipid/water solubilities, and ionization constants (pK a).
Statistical analysis. All data are presented as means Ϯ SE. Statistical comparisons were performed using Student's t-test (paired or unpaired) as appropriate. Differences were considered to be significant when P Ͻ 0.05.
RESULTS
Effect of hypoxia and AZ on pH i .
To test whether the mechanism by which AZ inhibited HPV in isolated lungs involved modulation of hypoxia-induced changes in PASMC pH i , pH i was measured during control conditions and after changing to hypoxic solution in the absence and presence of 100 M AZ (Fig. 2) . AZ alone caused a small but statistically significant decrease in resting pH i (Table 1 ). Exposure to 4% O 2 had no significant effect on PASMC pH i , with pH i measured at 7.23 Ϯ 0.02 during normoxia and 7.24 Ϯ 0.03 after 15 min of hypoxia (n ϭ 85 cells in 5 experiments). Similarly, hypoxia had no effect on pH i in PASMCs pretreated with AZ (7.22 Ϯ 0.03 to 7.24 Ϯ 0.03; n ϭ 55 cells in 4 experiments).
Effect ] i in response to hypoxia occurred within 7 min of beginning perfusion with hypoxic solution. On return to normoxia, [Ca 2ϩ ] i rapidly returned to normoxic levels. Application of AZ (10 -100 M) had no effect on basal [Ca 2ϩ ] i in PASMCs (Table 1) . AZ caused a concentration-dependent decrease in the hypoxia-induced rise in [Ca 2ϩ ] i , with a significant reduction in the peak change in [Ca 2ϩ ] i induced by hypoxia at both 30 and 100 M AZ (Fig. 3) . From the concentration-inhibition plot, the IC 50 (Fig. 4) . Following pretreatment with 100 (Table 1) . However, in contrast to the effects of AZ, EZ (Fig. 5) and BZ (Fig. 6 ) had no significant effect on the hypoxia-induced increase in [Ca 2ϩ ] i at any of the concentrations tested (10 -100 M). As with AZ, both EZ and BZ caused a significant decrease in resting pH i ( ] i response to hypoxia via a mechanism unrelated to CA inhibition, we determined the effects of an AZ-derivative compound in which the sulfonamide group responsible for CA inhibition was substituted with a methyl group (N-Meth-AZ). The purity of the compound was assessed by high-resolution fast atom bombardment mass spectrometry, which showed only one species to be present in the recrystallized sample. In contrast to AZ, BZ, and EZ, N-Meth-AZ (100 M) had minimal effect on basal pH i (7. (Fig. 8A) . To test whether the inhibitory effect of N-Meth-AZ on hypoxia-induced Ca 2ϩ responses was due to generalized cell ] i in response to KCl (60 mM) was similar in the presence (n ϭ 73 cells in 4 experiments) and absence (n ϭ 83 cells in 4 experiments) of 100 M N-Meth-AZ (Fig. 8B) .
Effect of AZ on E m . AZ has recently been proposed to alter the activation of Ca 2ϩ -activated K ϩ channels, causing hyperpolarization (29, 46, 47 (3) . The ability of the dye to measure changes in E m was first verified by measuring the response to 1) the K ϩ channel opener, pinacidil, which causes hyperpolarization; 2) KCl, which causes depolarization by reducing the gradient for K ϩ efflux; and 3) ET-1, which causes depolarization via inhibition of K ϩ channels (Fig. 9) . Baseline fluores- 
DISCUSSION
In this study, we found that inhibition of CA with AZ, BZ, or EZ caused a small but significant acid shift in PASMC pH i , consistent with a mild acidosis arising from loss of CA- BZ had no effect on the peak change in [Ca 2ϩ ]i induced by hypoxia at any of the concentrations tested. mediated facilitated CO 2 diffusion (44). Challenge with moderate hypoxia caused a significant increase in PASMC [Ca 2ϩ ] i that was prevented by AZ but not BZ or EZ. The lack of effect of BZ and EZ on the hypoxic response was not due to ineffective concentrations of these two more powerful CA inhibitors, as both reduced basal pH i to a similar or greater extent than did AZ. Moreover, N-Meth-AZ, which has no CA-inhibiting action (23) and had no effect on pH i , also prevented the hypoxia-induced increase in [Ca 2ϩ ] i . The inhibitory action of AZ and N-Meth-AZ on Ca 2ϩ signaling was specific for hypoxia, as no effect on KCl-induced Ca 2ϩ responses was observed. Finally, AZ had no effect on either resting E m or agonist-induced depolarization. These results suggest that AZ prevents a rise in [Ca 2ϩ ] i in response to hypoxia in PASMCs by a mechanism that does not involve intracellular acidification or a change in E m and is independent of CA inhibition.
CA inhibitors were originally developed as diuretics with primary action on the kidney to interfere in acid-base related ion transport events. Although their use as diuretics has been supplanted by more potent alternatives, they are presently used to treat glaucoma, metabolic alkalosis, epilepsy, and acute mountain sickness, conditions in which alteration in systemic acid-base status or CA-dependent ion transport can be beneficial. CA is expressed in most cells, and there have been 14 different isozymes identified. This rich diversity of expression has led some to search for nonclassical (i.e., non-acid-base) functions of the enzyme. Swenson et al. (45) showed that CA inhibition impairs ventilation-perfusion matching in the lung, a process that is thought to result from both O 2 -and CO 2 -dependent changes in bronchial and vascular smooth muscle tone. To directly test whether CA inhibition alters HPV, a major mechanism that maintains ventillation perfusion (V A /Q) matching, Deem et al. (7) found that AZ blunts and slows HPV in the isolated perfused rabbit lung. Iturriaga et al. (16) found similar effects on another hypoxia-sensitive response: the neural output of the peripheral receptors of the carotid body, which contain CA, as does vascular smooth muscle (3) .
The mechanism by which AZ prevents HPV in vivo may be multifactorial. The respiratory stimulation generated by an induction of metabolic acidosis leads to increased ventilation and thus enhanced alveolar PO 2 at any given inspired PO 2 (44) and thus a reduction of the primary stimulus to HPV. However, the prevention of HPV by AZ in isolated perfused lung preparations and awake animals, where ventilation and/or alveolar PO 2 are carefully controlled (7, 8, 15) , indicate that AZ can reduce HPV via mechanisms other than elevation of alveolar PO 2 .
In this study, we show that AZ acts directly on the vascular smooth muscle to inhibit [Ca 2ϩ ] i responses to hypoxia and that these effects do not depend on CA inhibition or intracellular acidification. In our cells, all three CA inhibitors (AZ, BZ, and EZ) resulted in a small but significant acid shift in basal pH i . This is consistent with CA inhibition-induced acidosis described in corneal endothelium (4), nonpigmented ciliary epithelium (52), lactotrophs (11), neuronal cells (19, 20) , and rat heart, brain, liver, and spleen tissue (36) , and rules out the possibility that, at least in the case of highly diffusible EZ, there was a lack of intracellular penetration of the drug. Our findings suggest that CA actively participates in regulation of basal pH i in PASMCs under normal conditions.
That AZ decreased pH i in PASMCs presented a possible mechanism for preventing HPV. Intracellular pH can modulate a number of cell functions, including PASMC contraction (9, 18) . While we observed no change in pH i when oxygen concentration was reduced, consistent with reports in systemic vascular smooth muscle (10, 12, 37) , previous studies in feline PASMCs demonstrated that moderate hypoxia caused an increase in pH i that was associated with smooth muscle cell contraction (22) . Moreover, HPV in isolated perfused rat lungs was enhanced when pH i was increased by addition of weak bases, whereas decreasing pH i by addition of weak acids or by inhibition of Na ϩ /H ϩ exchange blunted HPV (33) . If alkalinization of PASMCs during hypoxia contributes to HPV, a decrease in pH i , as seen with CA inhibitors, could have adverse effects on HPV and provide a mechanism for AZ-induced antagonism of HPV. This hypothesis is opposed, however, by results from experiments we performed to assess the effect of CA inhibition on PASMC Ca 2ϩ signaling during hypoxia. In PASMCs, hypoxia caused a significant, rapid, and reversible increase in [Ca 2ϩ ] i . This increase in [Ca 2ϩ ] i in response to hypoxia had previously been shown to require Ca 2ϩ influx (1, 6, 50) and was required for generation of HPV (25, 27, 34, 40 -42, 48) . We found that AZ inhibited the rise in [Ca 2ϩ ] i induced by hypoxia, suggesting an ability to mod- ulate Ca 2ϩ signaling. The effect of AZ was concentration dependent with a calculated IC 50 of 50 M. This concentration corresponds to the concentrations of AZ that inhibited HPV in isolated lungs and intact animals (7, 8) . In contrast, neither BZ nor EZ was able to alter the hypoxiainduced change in [Ca 2ϩ ] i , yet caused similar, if not greater, acidification of PASMCs.
We further investigated the possibility that the effects of AZ on HPV and hypoxia-induced Ca 2ϩ responses were independent of CA inhibition using N-Meth-AZ. As expected from data demonstrating a loss of CA inhibitory action in vitro (23) , substitution of one of the amines in the sulfonamide group with a methyl group resulted in the inability of the compound to induce acidification. However, N-Meth-AZ reduced the increase in [Ca 2ϩ ] i in response to hypoxia to a similar extent as the same concentration of AZ. Based on our data, we can therefore rule out inhibition of CA and consequent acidification as the mechanism by which AZ prevents hypoxia-induced Ca 2ϩ mobilization. AZ has been proposed to cause membrane hyperpolarization (5, 28, 29, 47) , which could act to decrease Ca 2ϩ influx through voltage-gated Ca 2ϩ channels. We found that AZ had no effect on resting E m in our cells, results consistent with findings in rat kidney (14) . The lack of a measurable effect of AZ on E m was not due to an inability to detect hyperpolarization in our system, as a decrease in cell fluorescence was readily observed in response to pinacidil, a K ϩ channel activator. One limitation of this study was that we were unable to consistently demonstrate a change in E m in response to hypoxia with DiBAC 4 (3) (data not shown) and thus could not determine directly the effect of AZ on hypoxia-induced depolarization. It is possible that the rate of change in PO 2 in our system was sufficiently slow to prevent observation of an E m response. Another possibility is that our cells do not exhibit hypoxia-induced depolarization, and/or the magnitude of change is below the threshold for detection. This would be consistent with data from several investigators who were able to elicit hypoxia-induced depolarization in isolated PASMCs only when cells were first depolarized with other agents (49) or severe PO 2 or chemical hypoxia were used (30, 53, 54) . Although significant depolarization was observed in canine PASMCs (31), the reproducibility of the response was unclear since only a single representative trace was presented. Other indirect evidence that would point away from AZ-induced hyperpolarization as the mechanism for repressed Ca 2ϩ mobilization during hypoxia would be that EZ was as effective as AZ in opening K Ca channels (46) but had no effect on the hypoxia-induced rise in [Ca 2ϩ ] i in our cells. It is also unlikely that AZ acts to repress depolarization by preventing inhibition of K ϩ channels since AZ did not alter depolarization in response to ET-1 or KCl (Fig. 9) , which increase E m via inhibition of voltage-gated K channels (39) and by reducing the gradient for K ϩ efflux, respectively.
While the results from experiments examining the effect of AZ on E m appear to rule out hyperpolarization-driven reduction in Ca 2ϩ influx as a mechanism of inhibited Ca 2ϩ mobilization in response to hypoxia, inhibitors of CA have also been shown to directly block a range of voltagedependent Ca 2ϩ channels (13, 17, 26, 55) , some of which have been shown to participate in HPV (25, 40 -42, 48 ). Thus we also tested the ability of AZ and N-Meth-AZ to inhibit Ca 2ϩ mobilization in response to KCl, which depends on Ca 2ϩ influx through voltage-gated Ca 2ϩ channels (38, 51) . In PASMCs, the KCl-induced increase in [Ca 2ϩ ] i was similar in magnitude to that induced by hypoxia but was unaffected by pretreatment with AZ or N-Meth-AZ. These results indicate that AZ had no effect on the activation of voltage-gated Ca 2ϩ channels and suggest that the effect of AZ on PASMC Ca 2ϩ -signaling during hypoxia was not due to toxicity or a nonspecific inability to mobilize intracellular Ca 2ϩ . The differential inhibitory effect of AZ on the increases in [Ca 2ϩ ] i in response to hypoxia and KCl might also point to the intriguing implication that hypoxia causes Ca 2ϩ influx through pathways other than L-type Ca 2ϩ channels, as recently suggested (51) .
In summary, we found that AZ blocks the rise in PASMC [Ca 2ϩ ] i that occurs in response to hypoxia by a mechanism independent of CA inhibition and its generation of a mild intracellular acidosis. AZ does not appear to exert its inhibitory effect on the hypoxia-mediated increase in [Ca 2ϩ ] in PASMCs by either changes in E m or by blockade of voltage-sensitive calcium channels. The molecular target or pathway that is altered by AZ, but not other sulfonamide CA inhibitors, and is responsible for HPV inhibition remains to be discovered. The use of compounds such as N-Meth-AZ, which are similar in structure to AZ but lack its CA-inhibiting activity (and attendant side effects), may prove beneficial in elucidating the action of AZ in blunting HPV and provide new directions to explore regarding therapeutic strategies.
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